Novel study finds IBD drugs protective against recurrent arterial events

Thiopurines and anti-TNF therapies are associated with reduced risk for ischaemic heart disease and cerebrovascular disease in patients with a history of acute events

Thiopurines and TNF inhibitors appear protective against recurrent acute arterial events in adults with inflammatory bowel disease, researchers have shown in the first study of its kind.

The European group says its findings point to a greater risk reduction for patients with Crohn’s disease compared with ulcerative colitis, and for those younger than age 55.

Overall, the large cohort study suggests that exposure to thiopurines or anti-TNF therapy cuts the risk of recurrent

Latest